These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 7362740)

  • 1. Antipyrine as an in vitro probe of mixed function oxidase activity [proceeding].
    Kahn GC; Boobis AR; Blair I; Brodie MJ; Davies DS
    Br J Clin Pharmacol; 1980 Mar; 9(3):284P. PubMed ID: 7362740
    [No Abstract]   [Full Text] [Related]  

  • 2. Mixed function oxidase activity in microsomal fractions of human liver biopsy specimens [proceedings].
    Boobis AR; Brodie MJ; Davies DS; Fletcher DR; Saunders JH
    Br J Clin Pharmacol; 1978 Nov; 6(5):449P-450P. PubMed ID: 728300
    [No Abstract]   [Full Text] [Related]  

  • 3. [Metabolism of antipyrine in man].
    Pautet F; Barret R; Daudon M; Mathian B
    Pathol Biol (Paris); 1985 Sep; 33(7):777-80. PubMed ID: 3909077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute toxicity of substrates of the mixed function oxidase system in normal and phenobarbital-pretreated mice.
    Litterst CL; Mimnaugh EG; Gram TE; Guarino AM; Simon RC
    J Toxicol Environ Health; 1975 Sep; 1(1):39-46. PubMed ID: 810600
    [No Abstract]   [Full Text] [Related]  

  • 5. Interactions between nutritional factors and drug biotransformations in man.
    Alvares AP; Anderson KE; Conney AH; Kappas A
    Proc Natl Acad Sci U S A; 1976 Jul; 73(7):2501-4. PubMed ID: 1065903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Altered biotransformation of phenazone, aminophenazone and codeine as evidence of early injury to rat liver after administration of carbon tetrachloride].
    Klinger W; Neugebauer A; Splinter FK
    Arch Toxikol; 1968; 23(3):178-85. PubMed ID: 5704785
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of the catecholamine-depleting agent 1-phenyl-3-(2-thiazolyl)-2-thiourea (U-14,624) on drug metabolism in the rat.
    Smith JR; Waters IW; Masten LW
    Biochem Pharmacol; 1980 Sep; 29(18):2425-30. PubMed ID: 7426048
    [No Abstract]   [Full Text] [Related]  

  • 8. Selectivity of cholestyramine treatment on hepatic mixed function oxidase activity.
    Bachmann K; Schwartz J; Forney R; Sherman G; Jauregui L
    Pharmacology; 1984; 29(3):128-41. PubMed ID: 6483959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative metabolism of benzo[a]pyrene and drugs in human liver.
    Kapitulnik J; Popper PJ; Conney AH
    Clin Pharmacol Ther; 1977 Feb; 21(2):166-76. PubMed ID: 837635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies of the mechanism of enzyme induction. XIV. Effect of age on the activity and inducibility of phenazone hydroxylases, aminophenazone-N-demethylase, codeine-O-demethylase and nitroreductase of the rat liver].
    Klinger W; Kusch T; Neugebauer A; Splinter FK; Ankermann H
    Acta Biol Med Ger; 1968; 21(3):257-69. PubMed ID: 5750773
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of anti-cancer drugs on the plasma disposition of antipyrine and the biliary excretion of phenolphthalein in the rat.
    Capel ID; Jenner M; Pinnock MH; Williams DC
    Biochem Pharmacol; 1978 May; 27(10):1413-6. PubMed ID: 697882
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of dietary selenium status on in vitro hepatic mixed-function oxidase enzymes of rats.
    Shull LR; Buckmaster GW; Cheeke PR
    J Environ Pathol Toxicol; 1979; 2(4):1127-38. PubMed ID: 448255
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma antipyrine half-life and hepatic microsomal antipyrine hydroxylase activity in rabbits.
    Statland BE; Astrup P; Black CH; Oxholm E
    Pharmacology; 1973; 10(6):329-37. PubMed ID: 4784365
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical pathophysiology of mixed function oxidase system (MFOS) induction.
    Brockway BF
    West J Nurs Res; 1979; 1(3):256-9. PubMed ID: 261717
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of temperature on mixed function amine oxidase intrinsic fluorescence and oxidative activity.
    Kitchell BB; Rauckman EJ; Rosen GM
    Mol Pharmacol; 1978 Nov; 14(6):1092-8. PubMed ID: 32477
    [No Abstract]   [Full Text] [Related]  

  • 16. Stimulation of mixed function oxidase system by ascorbic acid.
    Kachole MS; Makhija SJ; Pawar SS
    Indian J Exp Biol; 1978 Jun; 16(6):695-6. PubMed ID: 700798
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of nitrite on rabbit liver mixed-function oxidase activity.
    Duthu GS; Shertzer HG
    Drug Metab Dispos; 1979; 7(5):263-9. PubMed ID: 40763
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of estrogens on mixed function oxidase activity in healthy and injured liver.
    Kulcsár-Gergely J; Kulcsár A; Weisz G
    Acta Pharm Hung; 1982 Jan; 52(1):2-9. PubMed ID: 7058689
    [No Abstract]   [Full Text] [Related]  

  • 19. No impairment of antipyrine elimination by the selective anticholinergic drug pirenzepine.
    Paxton JW; Foote SE; Paton DM
    Digestion; 1983; 27(1):44-6. PubMed ID: 6688400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in hepatic heme biosynthetic capability and mixed function oxidase activity during ethionine exposure in rats.
    Woods JS
    Mol Pharmacol; 1978 Sep; 14(5):900-10. PubMed ID: 714028
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.